Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESCAT III: Very Low Dose Anticoagulation in Mechanical Heart Valve Patients
NCT00528671Phase 4Terminated
- Sponsor
- Heart and Diabetes Center North Rhine-Westphalia
- Start
- Jan 2006
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of phenprocoumon in thromboembolism, sponsored by Heart and Diabetes Center North Rhine-Westphalia. Started Jan 2006; status: terminated.
02
Drugs
phenprocoumon
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT00528671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528671.